Start a conversation ↗Knowledge centre
Selected developments shaping clinical research, bioequivalence and the regulatory environment in Malaysia, ASEAN and beyond.
Latest intelligence
Regional clinical-trial and pharmaceutical developments
Running first-in-human clinical trials for drugs in Malaysia - The StarMHRA strengthens regulatory partnership with Malaysia to advance healthcare innovation - National Health ExecutiveMalaysia to set up rare disease registry - Free Malaysia TodayA systematic review and meta-analysis of pharmacy education and practice on prevention and management of noncommunicable diseases in ASEAN countries - NatureMethods, products and development strategy
Chemotherapy Market Size, Share & Growth Report - Market Research FutureComplex Generics: Facts, Figures and Who They Benefit - Teva PharmaceuticalsImproving the FDA-EMA parallel scientific advice program to advance complex generics - STATEMA adopts five product-specific bioequivalence guidelines - Generics and Biosimilars InitiativeGuidance and announcements from medicines regulators
Asia-Pacific Roundup: TGA adopts 23 international scientific guidelines - RAPSQPS India Successfully Completes Week-Long US FDA Regulatory Inspection - Business WireTechnology influencing trial design and delivery
Quotient Sciences proprietary AI-enhanced solution optimizes formulation in clinical study - News-MedicalQtis.ai Unveils AI-Native Clinical Research Division - Medical Product OutsourcingLessons from Hundreds of Clinical Trials: AI’s Successes, Gaps, and Opportunities - Applied Clinical Trials OnlineAI-enabled clinical trials - Nature